全文获取类型
收费全文 | 23883篇 |
免费 | 1811篇 |
国内免费 | 58篇 |
专业分类
耳鼻咽喉 | 152篇 |
儿科学 | 591篇 |
妇产科学 | 370篇 |
基础医学 | 3183篇 |
口腔科学 | 370篇 |
临床医学 | 2948篇 |
内科学 | 4197篇 |
皮肤病学 | 238篇 |
神经病学 | 2271篇 |
特种医学 | 817篇 |
外科学 | 3275篇 |
综合类 | 367篇 |
一般理论 | 30篇 |
预防医学 | 3050篇 |
眼科学 | 565篇 |
药学 | 1826篇 |
中国医学 | 40篇 |
肿瘤学 | 1462篇 |
出版年
2023年 | 152篇 |
2022年 | 269篇 |
2021年 | 538篇 |
2020年 | 346篇 |
2019年 | 490篇 |
2018年 | 560篇 |
2017年 | 437篇 |
2016年 | 482篇 |
2015年 | 627篇 |
2014年 | 811篇 |
2013年 | 1061篇 |
2012年 | 1807篇 |
2011年 | 1773篇 |
2010年 | 1045篇 |
2009年 | 954篇 |
2008年 | 1619篇 |
2007年 | 1733篇 |
2006年 | 1603篇 |
2005年 | 1633篇 |
2004年 | 1573篇 |
2003年 | 1460篇 |
2002年 | 1290篇 |
2001年 | 256篇 |
2000年 | 243篇 |
1999年 | 284篇 |
1998年 | 263篇 |
1997年 | 186篇 |
1996年 | 182篇 |
1995年 | 146篇 |
1994年 | 154篇 |
1993年 | 128篇 |
1992年 | 137篇 |
1991年 | 123篇 |
1990年 | 113篇 |
1989年 | 101篇 |
1988年 | 111篇 |
1987年 | 117篇 |
1986年 | 93篇 |
1985年 | 95篇 |
1984年 | 86篇 |
1983年 | 86篇 |
1982年 | 50篇 |
1981年 | 52篇 |
1980年 | 39篇 |
1979年 | 38篇 |
1978年 | 45篇 |
1977年 | 30篇 |
1976年 | 30篇 |
1973年 | 30篇 |
1970年 | 30篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Toidi Adekambi Chris C. Ibegbu Stephanie Cagle Ameeta S. Kalokhe Yun F. Wang Yijuan Hu Cheryl L. Day Susan M. Ray Jyothi Rengarajan 《The Journal of clinical investigation》2015,125(5):1827-1838
BACKGROUND. The identification and treatment of individuals with tuberculosis (TB) is a global public health priority. Accurate diagnosis of pulmonary active TB (ATB) disease remains challenging and relies on extensive medical evaluation and detection of Mycobacterium tuberculosis (Mtb) in the patient’s sputum. Further, the response to treatment is monitored by sputum culture conversion, which takes several weeks for results. Here, we sought to identify blood-based host biomarkers associated with ATB and hypothesized that immune activation markers on Mtb-specific CD4+ T cells would be associated with Mtb load in vivo and could thus provide a gauge of Mtb infection.METHODS. Using polychromatic flow cytometry, we evaluated the expression of immune activation markers on Mtb-specific CD4+ T cells from individuals with asymptomatic latent Mtb infection (LTBI) and ATB as well as from ATB patients undergoing anti-TB treatment.RESULTS. Frequencies of Mtb-specific IFN-γ+CD4+ T cells that expressed immune activation markers CD38 and HLA-DR as well as intracellular proliferation marker Ki-67 were substantially higher in subjects with ATB compared with those with LTBI. These markers accurately classified ATB and LTBI status, with cutoff values of 18%, 60%, and 5% for CD38+IFN-γ+, HLA-DR+IFN-γ+, and Ki-67+IFN-γ+, respectively, with 100% specificity and greater than 96% sensitivity. These markers also distinguished individuals with untreated ATB from those who had successfully completed anti-TB treatment and correlated with decreasing mycobacterial loads during treatment.CONCLUSION. We have identified host blood-based biomarkers on Mtb-specific CD4+ T cells that discriminate between ATB and LTBI and provide a set of tools for monitoring treatment response and cure.TRIAL REGISTRATION. Registration is not required for observational studies.FUNDING. This study was funded by Emory University, the NIH, and the Yerkes National Primate Center. 相似文献
2.
3.
ABSTRACTA monocausal bacteriological understanding of infectious disease orients tuberculosis control efforts towards antimicrobial interventions. A bias towards technological solutions can leave multistranded public health and social interventions largely neglected. In the context of globalising biomedical approaches to infectious disease control, this ethnography-inspired review article reflects upon the implementation of rapid diagnostic technology in low- and middle-income countries. Fieldwork observations in Vietnam provided a stimulus for a critical review of the global rollout of tuberculosis diagnostic technology. To address local needs in tuberculosis control, health managers in resource-poor settings are readily cooperating with international donors to deploy novel diagnostic technologies throughout national tuberculosis programme facilities. Increasing investment in new diagnostic technologies is predicated on the supposition that these interventions will ameliorate disease outcomes. However, suboptimal treatment control persists even when accurate diagnostic technologies are available, suggesting that promotion of singular technological solutions can distract from addressing systemic change, without which disease susceptibility, propagation of infection, detection gaps, diagnostic delays, and treatment shortfalls persist. 相似文献
4.
5.
The molecular and clinical impact of hepatocyte growth factor, its receptor, activators, and inhibitors in wound healing 总被引:1,自引:0,他引:1
Kevin Conway MRCS ; Patricia Price PhD ; Keith G. Harding FRCS ; Wen G. Jiang MD 《Wound repair and regeneration》2006,14(1):2-10
Wound healing involves a number of cellular and molecular events, many of which are controlled by soluble growth factors. In the process of healing, hepatocyte growth factor, a cytokine known to act as mitogen, motogen, and morphogen, has been postulated to play multiple roles during several stages of this complex biological process. Produced primarily by stromal fibroblasts, hepatocyte growth factor regulates angiogenesis, vascular permeability, cell migration, matrix deposition and degradation, and other biological processes. The current article discusses recent progress in understanding the multiple roles played by this growth factor in tissue repair. 相似文献
6.
7.
8.
Chris Giles 《Canadian Medical Association journal》2002,167(7):786-787
9.
10.
Jeffery H Wootton Anthony B Ross Chris J Diederich 《International journal of hyperthermia》2007,23(8):609-622
PURPOSE: This study was designed to assess pelvic bone temperature during typical treatment regimens of transurethral ultrasound thermal ablation of the prostate to establish guidelines for limiting bone heating. METHODS: Treatment with transurethral planar, curvilinear, and sectored tubular applicators was simulated using an acoustic and biothermal pelvic model that accommodates applicator sweeping, boundary temperature control, and changes in perfusion and attenuation with thermal dose to more accurately model ultrasound energy penetration. The effects of various parameters including power and frequency (5-10 MHz) on bone heating were assessed for a range of prostate cross-sections (3-5 cm) and bone distances (1-3 cm). RESULTS: All devices can produce significant bone heating (temperatures >50 degrees C, thermal dose >240 EM(43 degrees C)) without optimization of applied frequency or power for bone <3 cm from the prostate boundary. In small glands ( approximately 3 cm) increasing operating frequency of curvilinear and planar devices can increase bone temperatures, whereas the tubular applicator can be used at 10 MHz to avoid likely bone damage. In larger prostates (4-5 cm wide) increasing frequency reduces bone heating but can substantially increase treatment time. Lowering power can reduce bone temperature but may increase thermal dose by increasing treatment duration. All applicators can be used to treat glands 4-5 cm with limited bone heating by selecting appropriate power and frequency. CONCLUSIONS: Pubic bone heating during ultrasound thermal therapy of the prostate can be substantial in certain situations. Successful realization of this therapy will require patient-specific treatment planning to optimally determine power and frequency in order to minimize bone heating. 相似文献